Birmingham Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.71M | Sell |
112,751
-295
| -0.3% | -$7.72K | 1.03% | 29 |
|
|
2026
Q1 | $3.17M | Hold |
113,046
| – | – | 1.34% | 23 |
|
|
2025
Q4 | $2.81M | Sell |
113,046
-6,800
| -6% | -$171K | 1.24% | 26 |
|
|
2025
Q3 | $3.05M | Sell |
119,846
-12,403
| -9% | -$306K | 1.4% | 24 |
|
|
2025
Q2 | $3.21M | Sell |
132,249
-30,994
| -19% | -$723K | 1.42% | 25 |
|
|
2025
Q1 | $4.14M | Sell |
163,243
-10,344
| -6% | -$271K | 1.56% | 24 |
|
|
2024
Q4 | $4.61M | Sell |
173,587
-13,063
| -7% | -$354K | 1.71% | 23 |
|
|
2024
Q3 | $5.4M | Buy |
186,650
+4,887
| +3% | +$143K | 1.96% | 20 |
|
|
2024
Q2 | $5.09M | Buy |
181,763
+1,559
| +0.9% | +$42.9K | 1.99% | 19 |
|
|
2024
Q1 | $5M | Buy |
180,204
+40,209
| +29% | +$1.12M | 1.84% | 20 |
|
|
2023
Q4 | $4.03M | Sell |
139,995
-2,363
| -2% | -$71.4K | 1.59% | 23 |
|
|
2023
Q3 | $4.72M | Buy |
142,358
+11,888
| +9% | +$420K | 1.95% | 17 |
|
|
2023
Q2 | $4.79M | Sell |
130,470
-11,214
| -8% | -$436K | 2% | 16 |
|
|
2023
Q1 | $5.78M | Sell |
141,684
-3,535
| -2% | -$153K | 2.31% | 12 |
|
|
2022
Q4 | $7.44M | Sell |
145,219
-989
| -0.7% | -$47.4K | 2.82% | 11 |
|
|
2022
Q3 | $6.4M | Sell |
146,208
-6,738
| -4% | -$327K | 2.84% | 9 |
|
|
2022
Q2 | $8.02M | Sell |
152,946
-380
| -0.2% | -$19.4K | 3.2% | 8 |
|
|
2022
Q1 | $7.94M | Sell |
153,326
-3,015
| -2% | -$156K | 2.77% | 8 |
|
|
2021
Q4 | $9.23M | Sell |
156,341
-1,125
| -0.7% | -$55.7K | 3.34% | 5 |
|
|
2021
Q3 | $6.77M | Sell |
157,466
-2,177
| -1% | -$96.4K | 2.6% | 10 |
|
|
2021
Q2 | $6.25M | Buy |
159,643
+2,090
| +1% | +$81.3K | 2.29% | 12 |
|
|
2021
Q1 | $5.71M | Buy |
157,553
+1,740
| +1% | +$61.8K | 2.13% | 13 |
|
|
2020
Q4 | $5.74M | Sell |
155,813
-8,435
| -5% | -$309K | 2.37% | 12 |
|
|
2020
Q3 | $5.72M | Sell |
164,248
-242
| -0.1% | -$8.48K | 2.6% | 10 |
|
|
2020
Q2 | $5.1M | Buy |
164,490
+4,147
| +3% | +$141K | 2.49% | 12 |
|
|
2020
Q1 | $4.96M | Sell |
160,343
-6,909
| -4% | -$235K | 2.74% | 11 |
|
|
2019
Q4 | $6.22M | Sell |
167,252
-2,168
| -1% | -$77.2K | 2.76% | 11 |
|
|
2019
Q3 | $5.78M | Sell |
169,420
-2,601
| -2% | -$94.6K | 2.66% | 12 |
|
|
2019
Q2 | $7.07M | Sell |
172,021
-3,422
| -2% | -$136K | 3.19% | 8 |
|
|
2019
Q1 | $7.07M | Sell |
175,443
-2,924
| -2% | -$117K | 3.17% | 8 |
|
|
2018
Q4 | $7.39M | Sell |
178,367
-1,107
| -0.6% | -$46K | 3.6% | 5 |
|
|
2018
Q3 | $7.5M | Sell |
179,474
-2,472
| -1% | -$95.2K | 3.1% | 7 |
|
|
2018
Q2 | $6.26M | Sell |
181,946
-2,736
| -1% | -$93.5K | 2.69% | 11 |
|
|
2018
Q1 | $6.22M | Sell |
184,682
-3,109
| -2% | -$107K | 2.58% | 11 |
|
|
2017
Q4 | $6.45M | Sell |
187,791
-2,150
| -1% | -$73.3K | 2.47% | 13 |
|
|
2017
Q3 | $6.43M | Sell |
189,941
-3,113
| -2% | -$100K | 2.56% | 14 |
|
|
2017
Q2 | $6.15M | Sell |
193,054
-163
| -0.1% | -$5.14K | 2.48% | 13 |
|
|
2017
Q1 | $6.27M | Buy |
193,217
+3,511
| +2% | +$111K | 2.54% | 13 |
|
|
2016
Q4 | $5.85M | Buy |
189,706
+4,065
| +2% | +$124K | 2.46% | 12 |
|
|
2016
Q3 | $6.2M | Sell |
185,641
-1,184
| -0.6% | -$39.6K | 2.74% | 8 |
|
|
2016
Q2 | $6.24M | Sell |
186,825
-23,622
| -11% | -$754K | 2.74% | 8 |
|
|
2016
Q1 | $5.92M | Buy |
210,447
+1,907
| +0.9% | +$54.5K | 2.41% | 16 |
|
|
2015
Q4 | $6.39M | Buy |
208,540
+1,156
| +0.6% | +$36.4K | 2.6% | 8 |
|
|
2015
Q3 | $6.18M | Sell |
207,384
-408
| -0.2% | -$13.1K | 2.7% | 5 |
|
|
2015
Q2 | $6.61M | Sell |
207,792
-1,250
| -0.6% | -$40.7K | 2.58% | 7 |
|
|
2015
Q1 | $6.9M | Buy |
209,042
+8,503
| +4% | +$270K | 2.62% | 8 |
|
|
2014
Q4 | $5.93M | Sell |
200,539
-11,318
| -5% | -$325K | 2.28% | 14 |
|
|
2014
Q3 | $5.94M | Buy |
211,857
+759
| +0.4% | +$21.3K | 2.25% | 17 |
|
|
2014
Q2 | $5.94M | Buy |
211,098
+1,612
| +0.8% | +$46K | 2.17% | 18 |
|
|
2014
Q1 | $6.38M | Sell |
209,486
-1,986
| -0.9% | -$59.2K | 2.42% | 10 |
|
|
2013
Q4 | $6.15M | Sell |
211,472
-10,367
| -5% | -$302K | 2.32% | 10 |
|
|
2013
Q3 | $6.05M | Buy |
221,839
+10,330
| +5% | +$281K | 2.4% | 11 |
|
|
2013
Q2 | $5.62M | Buy |
+211,509
| New | +$5.84M | 2.33% | 9 |
|
Other funds holding PFE
Birmingham Capital Management's PFE Position: Q2 2026 in Review
Birmingham Capital Management reduced its Pfizer (PFE) stake by 0.26% in Q2 2026, selling an estimated $7.72K and leaving 112,751 shares worth $2.71M. The position accounts for 1.03% of the portfolio, ranked #29.
Birmingham Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.23M in Q4 2021. 2,817 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Birmingham Capital Management held 112,751 shares of Pfizer worth $2.71M as of Q2 2026.
- Birmingham Capital Management sold 295 Pfizer shares in Q2 2026, an estimated $7.72K.
- Pfizer made up 1.03% of Birmingham Capital Management's portfolio in Q2 2026, its #29 holding.
- Birmingham Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Birmingham Capital Management's Pfizer position peaked at $9.23M in Q4 2021.
- 2,817 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.